BeStock  
Stocks › Biotechnology › STTK

Shattuck Labs STTK

US equityMarket cap rank #3632Biotechnology
$4.46 −$0.09 (-1.98%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $4.47 +0.22%
Open$4.48
Prev close$4.55
Day range$4.42 – $4.68
Volume1.03M
Market cap$454.22M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00-100.0% YoY
Operating profit-$27.05M-152.4% YoY
Net profit-$25.20M-150.6% YoY
Diluted EPS-$0.14+0.0% YoY
Free cash flow-$17.52M-94.7% YoY
Operating cash flow-$17.47M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$1.0MSep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-18.7MDec '24$-13.7MMar '25$-12.5MJun '25$-10.1MSep '25$-12.6MDec '25$-14.8MMar '26$-15.2MJun '26$-25.2MSep '26

Diluted EPS by quarter

-0.37Dec '24-0.27Mar '25-0.24Jun '25-0.14Sep '25-0.12Dec '25-0.13Mar '26-0.12Jun '26-0.14Sep '26

Free cash flow by quarter

$-17.4MDec '24$-12.0MMar '25$-10.4MJun '25$-9.0MSep '25$-8.5MDec '25$-13.4MMar '26$-10.3MJun '26$-17.5MSep '26

Annual revenue

$9.9MFY20$30.0MFY21$652.0KFY22$1.7MFY23$5.7MFY24$1.0MFY25

Profitability & balance sheet

Return on equity-47.2%
Return on assets-43.9%
Return on invested capital-49.4%
Current ratio15.80
Liabilities / assets6.9%
Cash & investments$196.31M
Total debt$1.56M
Net cash (debt)$194.76M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $0.00 $0.00 $0.00 $1.00M $0.00
Total Operating Revenue $0.00 $0.00 $0.00 $1.00M $0.00
Operating Expense $27.05M $16.16M $15.55M $52.51M $13.37M
Selling and Admin Expenses $5.48M $4.46M $4.60M $17.24M $4.32M
-General & Admin Expense $5.48M $4.46M $4.60M $17.24M $4.32M
Research & Development $21.57M $11.70M $10.95M $35.27M $9.06M
Operating Profit -$27.05M -$16.16M -$15.55M -$51.51M -$13.37M
Net Non-Operating Interest Income (Expense) $1.86M $1.03M $779,000.00 $2.70M $730,000.00
Non-Operating Interest Income $1.86M $1.03M $779,000.00 $2.70M $730,000.00
Other Income (Expense) -$12,000.00 -$26,000.00 -$1,000.00 -$4,000.00 $48,000.00
Other Non-Operating Income (Expenses) -$12,000.00 -$26,000.00 -$1,000.00 -$4,000.00 $48,000.00
Pretax Profit -$25.20M -$15.15M -$14.77M -$48.81M -$12.59M
Net Profit -$25.20M -$15.15M -$14.77M -$48.81M -$12.59M
Profit from Continuing Operations -$25.20M -$15.15M -$14.77M -$48.81M -$12.59M
Net Income to Parent Company -$25.20M -$15.15M -$14.77M -$48.81M -$12.59M
Net Income to Common Stockholders -$25.20M -$15.15M -$14.77M -$48.81M -$12.59M
Basic EPS -$0.14 -$0.12 -$0.13 -$0.70 -$0.12
Diluted EPS -$0.14 -$0.12 -$0.13 -$0.70 -$0.12

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $207.98M $220.67M $102.12M $91.03M $91.03M
Total Current Assets $201.60M $213.27M $93.75M $82.48M $82.48M
Cash and Cash Equivalents & Short-Term Investments $196.31M $208.30M $90.42M $78.07M $78.07M
-Cash and Cash Equivalents $61.76M $63.30M $90.42M $54.19M $54.19M
-Short Term Investments $134.55M $145.00M $0.00 $23.87M $23.87M
Other Current Assets $5.29M $4.97M $3.33M $4.41M $4.41M
Total Non-Current Assets $6.37M $7.39M $8.37M $8.55M $8.55M
Net PPE $3.63M $4.51M $5.35M $6.11M $6.11M
Investments and Advances $1.00M $1.00M $1.00M $1.00M $1.00M
-Long Term Equity Investment $1.00M $1.00M $1.00M $1.00M $1.00M
Other Non-Current Assets $1.74M $1.88M $2.02M $1.44M $1.44M
Total Liabilities $14.31M $9.53M $6.29M $8.64M $8.64M
Total Current Liabilities $12.76M $7.73M $4.25M $7.05M $7.05M
Payables $3.92M $3.94M $1.25M $2.10M $2.10M
-Accounts Payable $3.92M $3.94M $1.25M $2.10M $2.10M
Current Accrued Expenses $5.36M $1.03M $1.06M $1.11M $1.11M
Short-Term Debt and Capital Lease Obligation $897,000.00 $874,000.00 $852,000.00 $837,000.00 $837,000.00
-Current Capital Lease Obligation $897,000.00 $874,000.00 $852,000.00 $837,000.00 $837,000.00
Other Current Liabilities $261,000.00 $351,000.00 $335,000.00 $236,000.00 $236,000.00
Total Non-Current Liabilities $1.56M $1.80M $2.04M $1.58M $1.58M
Long Term Debt and Capital Lease Obligation $1.56M $1.80M $2.04M $1.58M $1.58M
-Long Term Capital Lease Obligation $1.56M $1.80M $2.04M $1.58M $1.58M
Total Equity $193.66M $211.14M $95.84M $82.39M $82.39M
Stockholders' Equity $193.66M $211.14M $95.84M $82.39M $82.39M
Capital Stock $10,000.00 $10,000.00 $7,000.00 $7,000.00 $7,000.00
-Common Stock $10,000.00 $10,000.00 $7,000.00 $7,000.00 $7,000.00
Additional Paid-In Capital $679.37M $671.64M $541.12M $512.91M $512.91M
Retained Earnings -$485.65M -$460.45M -$445.30M -$430.53M -$430.53M
Gains/Losses Not Affecting Retained Earnings -$62,000.00 -$63,000.00 $0.00 $6,000.00 $6,000.00
-Gross PPE – – – $22.79M $22.79M
-Accumulated Depreciation – – – -$16.67M -$16.67M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$17.47M -$10.19M -$13.42M -$39.88M -$8.49M
Net cash flow from continuing operations -$17.47M -$10.19M -$13.42M -$39.88M -$8.49M
Net Income from Continuing Operations -$25.20M -$15.15M -$14.77M -$48.81M -$12.59M
Depreciation & Depletion & Amortization $813,000.00 $851,000.00 $891,000.00 $3.69M $906,000.00
Other Non-Cash Items $811,000.00 -$549,000.00 $132,000.00 -$599,000.00 $132,000.00
Change in Working Capital $4.01M $2.13M -$2.05M -$785,000.00 $1.71M
-Change in Prepaid Assets -$322,000.00 -$1.64M $1.08M $1.82M $180,000.00
-Change in Payables and Accrued Expense $5.26M $3.32M -$2.87M -$1.76M $1.82M
-Change in Other Current Assets $4,000.00 $6,000.00 -$32,000.00 $79,000.00 -$12,000.00
-Change in Other Current Liabilities -$923,000.00 $441,000.00 -$225,000.00 -$922,000.00 -$278,000.00
Net cash flow from investing $11.73M -$144.95M $23.85M -$7.89M $20.00M
Net Cash Flow from Continuing Investing Activities $11.73M -$144.95M $23.85M -$7.89M $20.00M
Net PPE Purchase and Sale -$50,000.00 – – -$71,000.00 $0.00
Net Investment Purchase and Sale $11.78M -$144.81M $23.85M -$7.82M $20.00M
Financing Cash Flow $4.20M $128.01M $25.80M $44.57M $134,000.00
Net Cash Flow from Continuing Financing Activities $4.20M $128.01M $25.80M $44.57M $134,000.00
Net Common Stock Issuance -$301,000.00 $80.43M $20.56M $44.48M -$5,000.00
Proceeds from Stock Option Exercised $4.50M $47.59M $5.50M $164,000.00 $139,000.00
Net Other Financing Charges $0.00 -$7,000.00 -$262,000.00 -$65,000.00 $0.00
Ending Cash Balance $61.76M $63.30M $90.42M $54.19M $54.19M
Net Change in Cash -$1.54M -$27.12M $36.23M -$3.20M $11.64M
Beginning Cash Balance $63.30M $90.42M $54.19M $57.39M $42.55M
Free Cash Flow -$17.52M -$10.33M -$13.42M -$39.95M -$8.49M
Gain/Loss from Continuing Operations – – – $81,000.00 $34,000.00

Discussion

No comments yet — be the first to weigh in on STTK.

Sign in to join the discussion.

Scroll to Top